首页> 外文期刊>Journal of tissue engineering and regenerative medicine >Iron dose-dependent differentiation and enucleation of human erythroblasts in serum-free medium
【24h】

Iron dose-dependent differentiation and enucleation of human erythroblasts in serum-free medium

机译:无血清培养基中人成红细胞的铁剂量依赖性分化和去核

获取原文
获取原文并翻译 | 示例
           

摘要

Improvements in ex vivo generation of enucleated red blood cells are being sought for erythroid biology research, toward the ultimate goal of erythrocyte engineering for clinical use. Based upon the high levels of iron-saturated transferrin in plasma serum, it was hypothesized that terminal differentiation in serum-free media may be highly dependent on the concentration of iron. Here adult human CD34(+) cells were cultured in a serum-free medium containing dosed levels of iron-saturated transferrin (holo-Tf, 0.1-1.0mg/ml). Iron in the culture medium was reduced, but not depleted, with erythroblast differentiation into haemoglobinized cells. At the lowest holo-Tf dose (0.1mg/ml), terminal differentiation was significantly reduced and the majority of the cells underwent apoptotic death. Cell survival, differentiation and enucleation were enhanced as the holo-Tf dose increased. These data suggest that adequate holo-Tf dosing is critical for terminal differentiation and enucleation of human erythroblasts generated ex vivo in serum-free culture conditions. Published 2013. This article is a US Government work and is in the public domain in the USA.
机译:对于红系生物学研究,正在寻求去核去核红细胞的离体产生的改进,以实现临床用途的红细胞工程的最终目标。基于血浆血清中高水平的铁饱和转铁蛋白,假设无血清培养基中的终末分化可能高度依赖于铁的浓度。在这里,成年人CD34(+)细胞在无血清培养基中培养,该培养基含有一定剂量的铁饱和转铁蛋白(holo-Tf,0.1-1.0mg / ml)。随着成红细胞分化成血红蛋白化细胞,培养基中的铁减少但没有耗尽。在最低的Hol-Tf剂量(0.1mg / ml)下,终末分化显着降低,大多数细胞凋亡死亡。随着全息Tf剂量的增加,细胞存活,分化和去核作用增强。这些数据表明适当的holo-Tf剂量对于在无血清培养条件下离体产生的人成血红细胞的终末分化和去核至关重要。 2013年发布。本文是美国政府的工作,在美国属于公共领域。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号